[┐∵]┘ try EasyPronounce.com daily pronunciations

FDA Approval in Bladder Cancer, Breakthrough Therapy Designation in DLBCL, and More

Free Button: Daily News
Free Button: Daily News

  Info

Description

George R. Simon, MD, reports on an FDA approval in bladder cancer, a breakthrough therapy designation in diffuse large B-cell lymphoma, an ODAC hearing scheduled for a drug in HER2-positive breast cancer, an FDA elimination for REMS certification prior to select treatments, and 2 disappointing phase III results in non–small cell lung cancer and triple-negative breast cancer.

Tags

cancer oncology
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You
Old Cartoons on DVD. Visit and Bookmark: Cool90s.com!

Related

  FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and Breakthrough Designation in NSCLC   FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and a Breakthrough Designation in NSCLC   Cancer Advance of the Year, FDA Approval for CINV, Breakthrough Designation in TNBC, And More   Nivolumab Lung Cancer Approval Expanded, Abemaciclib Granted Breakthrough Status, and More   FDA Approvals in Breast Cancer and NSCLC, NDA Accepted in HCC, and More   FDA Approvals in ALL and Breast Cancer, Priority Reviews in CML and Follicular Lymphoma, and More   Breakthrough Designation in ALL, HIFU FDA Approval, Breast Cancer Screening Update, and More   FDA Approval in Breast Cancer, Breakthrough Designations in AML and Bladder Cancer, and More   FDA Approval in Carcinoid Syndrome Diarrhea, Priority Reviews in Bladder Cancer and NSCLC, and More   FDA Approval and 2 Priority Reviews in Bladder Cancer, and ASCO's Cancer Advance of the Year   FDA Approval in AML, NDA Submitted in Myeloma, Clinical Hold on CAR T-cell Therapy Trials, and More   21st Century Cures Act Passes and 2016 Highlights from SABCS and WCLC   FDA Approvals in NSCLC, Bladder Cancer, and Breast Cancer, and Death in CAR T-cell Therapy Trial   The FDA Approval of Atezolizumab in Bladder Cancer   FDA Approval of Durvalumab for Bladder Cancer   Durvalumab FDA Approval for Bladder Cancer   FDA approves breakthrough CAR-T therapy for leukemia   FDA Approval in AML, Priority Review Designation in NSCLC, and More   FDA Approvals in HCC and Gastric Cancer, ODAC Panel Splits on Adjuvant RCC Treatment, and More   Dr. Siefker-Radtke on FDA Approval of Frontline Atezolizumab in Bladder Cancer   John McCamant on Anti-Cancer Therapies   Niraparib Maintenance for Recurrent Ovarian Cancer   FDA Approvals in GVHD, CRC, and AML, a Priority Review in MCL, and More   Dr. Garcia on FDA Approval of Pembrolizumab in Bladder Cancer   FDA Approvals, Breakthrough Designations, Priority Reviews, and More   Gefitinib Approved for NSCLC, Atezolizumab Shrinks Bladder Tumors, and More   FDA Approves Treatment for Childhood Leukemia   FDA Approval in Lung Cancer, Priority Reviews in HCC and NHL, and an ODAC Recommendation   FDA Approvals in ALL, Ovarian Cancer, Priority Review in CTCL, and sNDA Submitted in RCC   FDA Approval and Priority Review in Ovarian Cancer, End of Part B Payment Model, and More   Psychedelic drug being looked at to treat PTSD   Breakthrough Therapy Designation in CSCC, 2017 ESMO Congress Highlights, and More   Dr. Siefker-Radtke on FDA Approval of Durvalumab in Bladder Cancer   Dr. Kelly on the FDA Approval of Ribociclib in HR+ Breast Cancer   FDA Approvals in Breast Cancer and Melanoma, Disappointing Results in HNSCC, and More   FDA Approvals in CRC, Blood Cancer Detection Diagnostic, and Alopecia, and More   FDA Approval of Durvalumab for Advanced Bladder Cancer   FDA Approvals in CRC, Blood Diagnostic, and Alopecia, and More   Dr. Balar on the Approval of Pembrolizumab for Bladder Cancer   Extended Adjuvant Therapy for HER2-Positive Breast Cancer   FDA Approval of Atezolizumab for Advanced Bladder Cancer   FDA Approval in Myeloma, Priority Review in ALL, and 2017 GU Cancers Symposium Highlights   'Our Cancer Drug Is For Rich Westerners, Not Poor Indians'   A Highly Effective Cancer Treatment Has Just Been Approved by the FDA   What's next in fighting cancer with polio virus?   Novartis Metastatic Breast Cancer Treatment   FDA Approval in MZL, Delay in Immunotherapy Combos in NSCLC, and 2017 GI Symposium Highlights   FDA Approval in CLL, Recommendation in NSCLC, Missed Endpoint in GBM Study, and More   FDA Approvals in Hematologic Malignancies, sBLA Accepted in Multiple Myeloma, and More   Breakthrough gene therapy approved in fight against cancer   FDA Approval: Frontline Ceritinib for ALK+ NSCLC   New gene therapy could win fight against cancer   Combined Immunotherapy and Chemotherapy for NSCLC   New treatment for dangerous form of cancer to be fast-tracked by FDA   Dr. Plimack on the Challenges With Available Immunotherapies for Bladder Cancer   FDA Approves First Gene Therapy To Successfully Treat Cancer | NBC Nightly News   Promising Parkinson's research in San Diego   FDA Approval in Lung Cancer, Promising Findings in Hodgkin Lymphoma, and More   FDA Approval in ALL, Priority Reviews in CML and Breast Cancer, and More   Frontline Atezolizumab for Advanced Bladder Cancer   Recent FDA Approval of Ribociclib as Upfront Therapy   FDA Working To Eliminate Orphan Designation Backlog   Cellectis CEO: Creating A Cancer Fighting Machine | Mad Money | CNBC   FDA Approval Sought in Multiple Myeloma, 2017 AACR Annual Meeting Highlights, and More   Key Considerations for Treating Recurrent Ovarian Cancer   Full FDA Approvals in Breast Cancer and Lung Cancer, Priority Reviews in ALL, and More   FDA Approves Breakthrough Cancer Treatment   FDA Approval of Brigatinib for ALK+ NSCLC   Bold cancer treatment granted breakthrough status   FDA pulls Keytruda from two clinical trials after deaths   Dr. Straus on FDA Approval of Pembrolizumab in Hodgkin Lymphoma   Personalised medicine could lead to a breakthrough in cancer in 2017   Dr. Steinberg on the FDA Approval of Atezolizumab in Bladder Cancer   FDA: Ecstasy 'Breakthrough Therapy' for PTSD   Pembrolizumab in Newly Diagnosed Squamous NSCLC

Popular Today

  56 Days Later, The Stanley Cup Final Begins ...   Meet the Family Rescuing Animals Left Behind from Oregon's Wildfires   Joe Biden spreads debunked Post Office conspiracy theories   IPL 2020: ‘It’s just one game’, says Kings XI’s Mayank Agarwal after losing to DC in first match   Swab test price regulation recommendation, naisumite na ng DOH kay Pangulong Duterte   Quran Ki Nihayat Aham Ayaat | Peyam e Subh With Aneeq Ahmed | 21 September 2020 | HK1K   "No le sirve a Morena la polarización, es tiempo de la unidad"; Mario Delgado   Beam Global officially changes name from Envision Solar to more accurately reflect its activities   Gharama za mazishi kusimamiwa na serikali   Battle Over Supreme Court Nominee Will Get Nasty: Why Ginsburg Wouldn’t Approve   Nurses and midwives from Malta give Pope Francis scrub top signed by medical staff   Massive rescue operation to try and save 270 whales stranded on Tasmania's West Coast | ABC News   Lori Loughlin's Prison May Include Yoga, Pilates & More   LIVE: #GlobalBusiness 18GMT 18/09/2020   Massachusetts Unemployment Rate Improves To 11.3%   Joe Biden agreed AOC's anti-energy Green New Deal doesn't go too far   24 Oras: 24 Oras News Alert - 11:25 AM | September 21, 2020   Union Twp. Police looking for person responsible for stealing, destroying political signs   Bears & Trubisky come out strong, struggle late but hold off Giants in Week 2 | Football Aftershow   9pm News Bulletin | 20 Sep 2020 | 24 News HD   Reconstrucción total por sismo estará lista hasta 2022: César Cravioto   Political News | राज्यसभेच्या ८ खासदारांचे एका आठवड्यासाठी निलंबन | Marathi News   Cari's Champions: Kalin Bennett | The Arena   Xinjiang, My home | Tiling expert Tursun Tohti   Several Kenosha schools move to virtual learning due to 'surge in employee absences'   Schools in Kibwezi undergo facelift ahead of reopening   Tekashi 6ix9ine Says Lil Durk Needs Drake To Succeed After 'The Voice' Billboard Numbers Drop   HasanAbi reacts to Joe Rogan's Apology   Sacramento remembers Justice Ruth Bader Ginsburg   Trump speaks at Minnesota rally before news of Ginsburg's death broke   Volunteers unite for coastal cleanup drive on Puri beach   Ian Rapoport on who has a better shot at the playoffs: Jets or Giants | The Tailgate | SNY   Guilford Road and Oakland Mills Road project moving forward   Monster Hunter Rise Nintendo Direct Kinda Funny Live Reactions   Senator Moi meets Governor Waiguru and other women leaders   | NATIONAL REMINDER | What happened to the alleged gold scam that rocked Kenya in 2019?   WATCH | 1 000 years old and 36 metres tall: Tsitsikamma's big tree site is open for business   Trump to block TikTok, WeChat downloads Sept 20   9-21-2020 High Island, Tx Tropical Storm Beta TDOT fights storm surge on highway, drone   Tracing underway in Sydney for taxi passengers exposed to COVID-19 | ABC News   Inside San Francisco's First COVID-Compatible Barber Collective   Jupiter Saturn and the Moon will Put on a Show this Week - The Bright Star Fomalhaut is Nearby   This Is What a Supreme Court Vacancy Means for the Election   Biden admits he will "transition" fracking workers out of their jobs   Unang Balita sa Unang Hirit: September 21, 2020 [HD]   Pasahero sa jeep, bus, babawasan sunod sa 1-meter public transpo distance rule   Anurag Kashyap’s ex-wife Kalki Koechlin slams sexual assault claims against him   AWANI 7:45 [21/09/2020]: Permohonan ditolak | Kluster Kuarters | Siasatan dijalankan   JKPP arah hentikan kerja di Lebuhraya SUKE   | LESSONS FROM RWANDA | Special report on how Rwanda is managing COVID-19   View All Today's Popular Videos